Hesperidin RCT in MS
Recruiting · NCT07452562 · Interventional (participants receive a specific treatment) · Lead sponsor: Swansea University
View the official record on ClinicalTrials.gov →Interventions studied
HesperidinPlacebo
What this trial is about
This study is a randomised, double-blind, placebo-controlled trial investigating the effects of Hesperidin supplementation on cognitive function, fatigue, and stress. Participants will be randomly assigned to receive either 500mg of Hesperidin or a matching placebo daily for 12 weeks. The primary outcome is fatigue, with secondary outcomes including cognitive performance and mood. The trial seeks to determine if this dietary intervention offers symptom-alleviating benefits.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Diagnosis of Multiple Sclerosis, Aged 18 years or older.
Exclusion criteria
- Known food allergies, intolerances, or significant gastrointestinal (GI) problems, Participants under the age of 18 years.
Where it is running
1 location listed.
- FHMLS, Nutrition Lab - Swansea, Wales, United Kingdom